Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Verrica Pharmaceuticals (1NE0) vs. Competitors

1 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:1NE0Verrica PharmaceuticalsEUR 2.60EUR 45.20M-1.26-31.22%Strong BuyUnlock the DE:1NE0 analyst price target with TipRanks PremiumDE:1NE0Unlock the DE:1NE0 top-analyst price target with TipRanks Premium
ELUTElutia$0.81$35.96M0.6322.91%Moderate BuyUnlock the ELUT analyst price target with TipRanks PremiumDE:1NE0 vs ELUTUnlock the ELUT top-analyst price target with TipRanks Premium
EVAXEvaxion Biotech$2.03$16.93M-0.33-58.40%Strong BuyUnlock the EVAX analyst price target with TipRanks PremiumDE:1NE0 vs EVAXUnlock the EVAX top-analyst price target with TipRanks Premium
LIMNLiminatus Pharma$2.81$3.77M-0.12-94.98%―Unlock the LIMN analyst price target with TipRanks PremiumDE:1NE0 vs LIMNUnlock the LIMN top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:1NE0Verrica Pharmaceuticals2.60-1.14-30.48%
ELUTElutia0.810.2031.71%
EVAXEvaxion Biotech2.03-3.31-61.99%
LIMNLiminatus Pharma2.81-49.69-94.65%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts